| Literature DB >> 31731609 |
Hanan Alfawaz1,2, Alsoodeeri Fahadah Naeef1, Kaiser Wani2, Malak Nawaz Khan Khattak2, Shaun Sabico2, Abdullah M Alnaami2, Nasser M Al-Daghri2.
Abstract
The present study aimed to investigate the changes in dietary patterns of adult Saudis with prediabetes who underwent a six-month lifestyle modification program. A total of 160 Saudis with prediabetes (baseline fasting glucose 5.6-6.9 mmol/L), aged 20-60 years, were enrolled in one of the two arms: A one-time general advice about lifestyle modification (GA group) at orientation or a well-structured and monitored nutrition and lifestyle counseling for six months (guidance group). Fasting blood samples and a dietary recall for daily intakes of macro/micronutrients using a validated computerized food database "ESHA-the Food Processor Nutrition Analysis program" were collected pre- and post-intervention. Compliance to reference daily intake (RDI) was also calculated at both time points. At baseline, overall, severe deficiencies in the majority of micronutrient intakes were observed. Post intervention, clinically significant improvements in the glycemic indices (fasting glucose and insulin resistance) were seen over time in the guidance group. Also, significant improvements in dietary habits and physical activity levels were more apparent in the guidance group than the GA group, particularly in the daily intakes of total carbohydrate (46.9% compliance post vs. 20.3% at baseline); dietary fiber (21.9% vs. 3.1%); and some micronutrients like vitamin B6 (21.3% vs. 6.7%), vitamin B12 (45.3% vs. 28%), vitamin C (21.9% vs. 7.8%), riboflavin (40% vs. 10.7%), niacin (41.3% vs. 14.7%), magnesium (18.8% vs. 4.7%), iron (54.7% vs. 34.4%), and copper (37.3% vs. 13.3%). The study highlights the effects of a six-month lifestyle modification program in improving dietary micronutrient intakes of Saudis with prediabetes. Since micronutrient intake was observed to be low, fortification of these micronutrients in the Saudi diet is recommended.Entities:
Keywords: lifestyle modification; micronutrients; minerals; nutrition guidance; pre-diabetes; recommended dietary intakes
Mesh:
Substances:
Year: 2019 PMID: 31731609 PMCID: PMC6893589 DOI: 10.3390/nu11112775
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Flow chart detailing the participation of participants and their allocation to treatment groups.
General, anthropometric, and biochemical characteristics of study groups at baseline.
| Parameters | GA | Guidance | |
|---|---|---|---|
|
| |||
| 20–29 | 7 (9.5) | 2 (3.2) | |
| 30–39 | 34 (44.6) | 26 (41.3) | |
| 40–49 | 29 (39.2) | 34 (52.4) | NS |
| 50–60 | 5 (6.8) | 2 (3.2) | |
|
| NS | ||
| Married | 64 (85.1) | 56 (87.5) | |
| Not married | 11 (14.9) | 8 (12.5) | |
|
| NS | ||
| Elementary | 3 (4.1) | 2 (3.3) | |
| Secondary | 2 (2.7) | 2 (3.3) | |
| Undergraduate | 16 (21.9) | 17 (26.2) | |
| Graduate | 47 (61.6) | 40 (53.9) | |
| Post graduate | 7 (9.6) | 3 (3.5) | |
|
| NS | ||
| Male | 41 (54.7) | 26 (40.6) | |
| Female | 34 (45.3) | 38 (59.4) | |
| Overweight | 37 (49.3) | 24 (37.5) | NS |
| Obese | 33 (44.0) | 34 (53.1) | |
| Age (years) | 43.3 ± 6.7 | 43.4 ± 5.6 | NS |
| BMI (kg/m2) | 30.4 ± 4.3 | 32.3 ± 6.2 | 0.04 |
| Fasting Glucose (mmol/L) | 6.1 ± 0.8 | 6.0 ± 0.7 | NS |
| HbA1C | 5.6 ± 0.8 | 5.6 ± 0.6 | NS |
| Insulin (μU/mL) | 16.52 (15.7,18.1) | 16.80(16.5,20.3) | 0.06 |
| HOMA-IR | 4.36 (4.1,4.8) | 4.51 (4.2,5.3) | 0.36 |
Note: NS: p-value not significant in overall subgroups. HOMA-IR is homeostatic model assessment for insulin resistance. Data presented as mean ± SD for continuous normal variables; medians (25th percentile, 75th percentile) for continuous non-normal variables; and N (%) for categorical variables. The difference between groups at baseline was calculated by independent samples t-test and Mann–Whitney U-test for Gaussian and non-Gaussian variables, respectively, and χ² test for categorical variables. p < 0.05 is taken as significant.
Body mass index (BMI), glycemic profile, and physical activity changes of groups over time.
| Parameters | GA (N = 75) | Guidance (N = 64) | Interaction | ||||
|---|---|---|---|---|---|---|---|
| Baseline | 6 months |
| Baseline | 6 months |
| ||
| BMI | 30.42 ± 4.3 | 30.83 ± 4.3 | 0.02 | 32.34 ± 6.2 | 31.77 ± 6.7 | 0.002 | 0.53 |
| Fasting glucose (mmol/L) | 6.06 ± 0.8 | 5.87 ± 1.1 | 0.15 | 6.03 ± 0.7 | 5.70 ± 1.0 | 0.01 | 0.005 |
| Hba1c (%) | 5.62 ± 0.8 | 5.41 ± 1.1 | 0.07 | 5.61 ± 0.6 | 5.35 ± 1.0 | 0.03 | 0.005 |
| Insulin (μU/mL) | 16.52 (15.7,18.1) | 15.98 (15.8,18.4) | 0.02 | 16.80 (16.5,20.3) | 16.05 (15.4,18.8) | 0.003 | 0.06 |
| HOMA-IR | 4.36 (4.1, 4.8) | 4.19 (3.8, 4.8) | 0.07 | 4.51(4.2, 5.2) | 4.09 (3.4, 4.7) | <0.01 | 0.034 |
| Moderate Physical Exercise/week | 2.00 (1.3, 3.0) | 2.00 (1.5, 2.5) | 0.89 | 2.3 (1.5, 3.0) | 2.6 (1.3, 3.6) | 0.029 | 0.07 |
| Vigorous Physical Exercise/week | 0.50 (0.3, 1.4) | 0.60 (0.3, 1.3) | 0.78 | 0.40 (0.2, 0.9) | 1.40 (1.2, 1.6) | <0.01 | 0.017 |
Note: HOMA-IR is homeostatic model assessment for insulin resistance. Data presented as mean ± SD for continuous normal variables; medians (25th percentile, 75th percentile) for continuous non-normal variables. The difference within groups compared with baseline was calculated by repeated measures t-test and Wilcoxon signed-rank test for Gaussian and non-Gaussian variables, respectively. Interaction p-value represents the overall intervention effect between the groups. p-value < 0.05 is considered significant.
Changes over time in nutrient intakes.
| Parameters | GA (N = 75) | Guidance (N = 64) | Interaction | ||||
|---|---|---|---|---|---|---|---|
| Baseline | 6 months |
| Baseline | 6 months |
| ||
| Energy (kcal/day) | 2285.2 (2025, 2628) | 2251.8 (1957, 2828) | 0.97 | 2230.7 (1982, 2814) | 2042.4 (1728, 2457) | 0.11 | 0.20 |
| Macronutrients | |||||||
| Carbohydrate (g/day) | 251.0 (198.7, 301.9) | 243.1 (198.5, 326.3) | 0.74 | 229.5 (197.2, 289.1) | 205.3 (149.0, 263.8) | 0.046 | 0.01 |
| Total Fiber (g/day) | 8.4 (6.2, 11.9) | 13.4 (7.5, 17.5) | 0.001 | 8.3 (5.0, 10.9) | 13.1 (11.1, 16.6) | <0.001 | 0.45 |
| Protein (g/day) | 90.2 (70.2, 107.0) | 91.4 (71.7, 106.8) | 0.78 | 91.4 (71.7, 103.8) | 82.5 (70.2, 95.2) | 0.08 | 0.05 |
| Total Fat (g/day) | 72.8 (63.1, 92.9) | 69.4 (60.3, 91.9) | 0.23 | 70.0 (59.5, 84.3) | 63.2 (57.0, 75.5) | 0.12 | 0.06 |
| SF (g/day) | 25.4 (20.8, 33.6) | 25.4 (19.8, 33.6) | 0.61 | 25.5 (19.0, 32.1) | 20.3 (14.1, 31.1) | 0.09 | 0.04 |
| MUFA (g/day) | 25.1 (23.2, 31.7) | 25.0 (20.6, 33.5) | 0.53 | 25.0 (20.2, 29.8) | 24.4 (18.7, 29.8) | 0.49 | 0.12 |
| PUFA (g/day) | 17.4 (15.4, 23.6) | 18.8 (15.4, 24.5) | 0.21 | 19.8 (16.1, 24.2) | 19.8 (16.1, 24) | 0.94 | 0.14 |
|
| |||||||
| Vit. A (μg RAE/d) | 283.3 (253.2, 525.5) | 370.4 (287.1, 504.1) | 0.26 | 226.5 (139.9, 461.3) | 437.5 (310.6, 547.1) | 0.001 | 0.65 |
| Thiamine (mg/day) | 0.44 (0.4, 0.6) | 0.49 (0.4, 0.7) | 0.16 | 0.31 (0.2, 0.4) | 0.66 (0.5, 0.8) | <0.001 | 0.81 |
| Riboflavin (mg/day) | 0.76 (0.6, 1) | 0.80 (0.6, 1.2) | 0.09 | 0.74 (0.6, 1.0) | 1.1 (0.9, 1.5) | <0.001 | 0.01 |
| Niacin (mg/day) | 6.8 (5.4, 11.4) | 9.4 (6.7, 14.7) | 0.11 | 8.9 (5.5, 14.5) | 15.5 (12.1, 20.9) | <0.001 | <0.001 |
| Vitamin B6 (mg/day) | 0.51 (0.4, 0.8) | 0.67 (0.5, 1) | 0.002 | 0.69 (0.5, 0.9) | 1.0 (0.8, 1.4) | <0.001 | <0.001 |
| Folate (μg/day) | 95.8 (67.5, 130.8) | 115.3 (87.4, 168.6) | 0.001 | 85.8 (59.8, 121.3) | 154.0 (127.6, 188.8) | <0.001 | 0.18 |
| Vitamin B12 (μg/day) | 1.5 (0.9, 2.2) | 1.7 (0.8, 2.5) | 0.69 | 1.7 (1.2, 3.3) | 2.7 (1.8, 3.6) | 0.018 | 0.041 |
| Vitamin C (mg/day) | 48.9 (20.3, 70.2) | 45.6 (25.6, 61.9) | 0.68 | 38.0 (19.7, 49) | 47.8 (36.3, 79.6) | <0.001 | 0.77 |
| Vitamin E (mg/day) | 3.8 (2.9, 5.8) | 5.2 (3.7, 7.5) | 0.001 | 4.6 (3.5, 5.7) | 7.1 (5.4, 9.4) | <0.001 | 0.003 |
|
| |||||||
| Calcium (mg/day) | 449.2 (313.5, 636.7) | 514.8 (349.2, 724.8) | 0.68 | 350.1 (243.5, 518.2) | 460.7 (366.7, 667.5) | 0.005 | 0.12 |
| Phosphorus (mg/day) | 535.8 (379, 740.5) | 629.1 (518.6, 820.6) | 0.037 | 652.8 (426.3, 886.0) | 914.2 (732.9, 1096.6) | <0.001 | <0.001 |
| Magnesium (mg/day) | 146.2 (125.6, 199.3) | 192.8 (156.6, 252.7) | 0.001 | 167.3 (129.5, 215.4) | 282.1 (227.7, 354.5) | <0.001 | <0.001 |
| Iron (mg/day) | 8.0 (6.2, 10.0) | 9.1 (6.9, 11.2) | 0.06 | 7.1 (5.1, 10.8) | 13.8 (11.6, 18) | <0.001 | 0.01 |
| Copper (μg/day) | 480 (440, 780) | 650 (490, 890) | 0.009 | 490 (345, 735) | 900 (780, 1130) | <0.001 | 0.03 |
| Sodium (g/day) | 1.9 (1.4, 2.7) | 2.2 (1.4, 2.9) | 0.32 | 2.0 (1.5, 2.5) | 3.0 (2.3, 3.4) | <0.001 | 0.01 |
| Potassium (g/day) | 1.4 (1.2, 1.8) | 1.8 (1.5, 2.2) | 0.001 | 1.4 (1.1, 2.1) | 2.6 (1.8, 3.0) | <0.001 | 0.01 |
| Zinc (mg/day) | 6.5 (5.2, 7.8) | 6.5 (5.3, 7.5) | 0.62 | 6.3 (5.1, 6.7) | 6.4 (5.4, 7.4) | 0.46 | 0.63 |
Note: The data are generated by calculating the average daily intake of macro as well as micronutrients from a three-day dietary recall of the study participants at baseline and end of study. Data are presented as median (25th percentile, 75th percentile). The difference within groups (p) at end of study was compared with baseline by Wilcoxon signed-rank test. Interaction p-value represents the difference between the groups post intervention. “SF” is saturated fat, “MUFA” and “PUFA” are mono- and polyunsaturated fatty acids, respectively. p-value < 0.05 is considered significant.
Percentage changes in recommended dietary intakes in the two study groups.
| Nutrients | RDI (M/F) | GA (N = 75) | Guidance (N = 64) | ||||
|---|---|---|---|---|---|---|---|
| B | ES |
| B | ES |
| ||
| Total Energy | ≤RDI_Energy 1 | 40.0 | 38.7 | 1.00 | 39.1 | 50.0 | 0.28 |
|
| |||||||
| Protein | ≤(0.8xBody weight) * | 8.0 | 12.0 | 0.55 | 20.3 | 23.4 | 0.06 |
| Carbohydrate | ≤35% of RDI Energy * | 17.3 | 25.3 | 0.29 | 20.3 | 46.9 | 0.003 |
| Total Fiber | ≥ 25 g/day * | 2.7 | 21.3 | 0.001 | 3.1 | 21.9 | 0.002 |
| Total Fat | ≤25% of RDI Energy * | 28.0 | 33.3 | 0.56 | 31.3 | 39.1 | 0.38 |
|
| |||||||
| Vitamin A | ≥ 900/700 μg/day ₤ | 8.0 | 8.0 | 1.00 | 6.3 | 12.5 | 0.39 |
| Thiamine | ≥ 1.2/1.1 mg/day | 1.3 | 4.0 | 0.64 | 4.7 | 6.3 | 1.00 |
| Riboflavin | ≥ 1.2/1.1 mg/day | 15.6 | 28.1 | 0.12 | 10.7 | 40.0 | <0.01 |
| Niacin | ≥ 16/14 mg/day ₤ | 20.3 | 34.4 | 0.06 | 14.7 | 41.3 | <0.01 |
| Vitamin B6 | ≥ 1.3,1.7#/1.3,1.5# mg/day ₤ | 10.9 | 17.2 | 0.45 | 6.7 | 21.3 | 0.01 |
| Folate | ≥ 400 μg/day *,₤ | 0.0 | 1.3 | - | 0.0 | 1.6 | - |
| Vitamin B12 | ≥ 2.4 μg/day * | 34.4 | 40.6 | 0.50 | 28.0 | 45.3 | 0.04 |
| Vitamin C | ≥ 90/75 mg/day ₤ | 18.7 | 21.3 | 0.83 | 7.8 | 21.9 | 0.02 |
| Vitamin E | ≥ 15 mg/day *,₤ | 0.0 | 0.0 | - | 0.0 | 0.0 | - |
|
| |||||||
| Calcium | ≥ 1000/1000,1200 # mg/day ₤ | 6.7 | 6.7 | 1.00 | 4.7 | 4.7 | 1.00 |
| Phosphorus | ≥ 700 mg/day *,₤ | 38.7 | 62.7 | 0.003 | 40.6 | 56.3 | 0.11 |
| Magnesium | ≥ 420/320 mg/day ₤ | 4.0 | 12.0 | 0.15 | 4.7 | 18.8 | 0.02 |
| Iron | ≥ 8/18,8 # mg/day ₤ | 22.7 | 40.0 | 0.02 | 34.4 | 54.7 | 0.03 |
| Copper | ≥ 900 μg/day *,₤ | 18.8 | 34.4 | 0.08 | 13.3 | 37.3 | <0.01 |
| Sodium | ≤(1.5,1.3#,2.3₤) * g/day | 29.3 | 12.0 | 0.007 | 29.7 | 21.9 | 0.38 |
| Potassium | ≥ 4.7 * g/day | 0.0 | 0.0 | - | 0.0 | 0.0 | - |
| Zinc | ≥ 11/8 mg/day ₤ | 14.7 | 6.7 | 0.15 | 4.7 | 9.4 | 0.45 |
Note: The data are generated by calculating the percentages of participants following RDI for each macro/micronutrient listed in the table at baseline (B) and end of study (ES). RDA was used only for nutrients where a defined tolerable upper limit (UL) was absent. 1 RDI_Energy is calculated by using recommendations by institute of medicine of the national academics and is explained in the methods section. * indicates same RDI for male (M) and female (F); # indicates RDI for age 50 and above; and ₤ indicates UL is considered in the criteria for calculating the percentages. The data are given in percentages of study participants following criteria used in third column. The difference within groups at end of study was compared with baseline by McNemar chi-square test. p-value < 0.05 is considered significant.